Fehrmann RSN - Search Results

1

Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database.

Moek KL, Fehrmann RSN, van der Vegt B, de Vries EGE, de Groot DJA. Moek KL, et al. Among authors: fehrmann rsn. Am J Pathol. 2018 Sep;188(9):1973-1981. doi: 10.1016/j.ajpath.2018.05.014. Epub 2018 Jun 21. Am J Pathol. 2018. PMID: 29935166 Free article.

2

Profiling studies in ovarian cancer: a review.

Fehrmann RS, Li XY, van der Zee AG, de Jong S, Te Meerman GJ, de Vries EG, Crijns AP. Fehrmann RS, et al. Oncologist. 2007 Aug;12(8):960-6. doi: 10.1634/theoncologist.12-8-960. Oncologist. 2007. PMID: 17766655 Free article. Review.

3

Evidence based selection of housekeeping genes.

de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA, de Vries EG, van der Zee AG, te Meerman GJ, ter Elst A. de Jonge HJ, et al. PLoS One. 2007 Sep 19;2(9):e898. doi: 10.1371/journal.pone.0000898. PLoS One. 2007. PMID: 17878933 Free PMC article.

4

A new perspective on transcriptional system regulation (TSR): towards TSR profiling.

Fehrmann RS, de Jonge HJ, Ter Elst A, de Vries A, Crijns AG, Weidenaar AC, Gerbens F, de Jong S, van der Zee AG, de Vries EG, Kamps WA, Hofstra RM, Te Meerman GJ, de Bont ES. Fehrmann RS, et al. PLoS One. 2008 Feb 20;3(2):e1656. doi: 10.1371/journal.pone.0001656. PLoS One. 2008. PMID: 18297136 Free PMC article.

5

Survival-related profile, pathways, and transcription factors in ovarian cancer.

Crijns AP, Fehrmann RS, de Jong S, Gerbens F, Meersma GJ, Klip HG, Hollema H, Hofstra RM, te Meerman GJ, de Vries EG, van der Zee AG. Crijns AP, et al. PLoS Med. 2009 Feb 3;6(2):e24. doi: 10.1371/journal.pmed.1000024. PLoS Med. 2009. PMID: 19192944 Free PMC article.

6

Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer.

Boelens MC, van den Berg A, Fehrmann RS, Geerlings M, de Jong WK, te Meerman GJ, Sietsma H, Timens W, Postma DS, Groen HJ. Boelens MC, et al. J Pathol. 2009 Jun;218(2):182-91. doi: 10.1002/path.2520. J Pathol. 2009. PMID: 19334046

7

A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer.

Heijink DM, Fehrmann RS, de Vries EG, Koornstra JJ, Oosterhuis D, van der Zee AG, Kleibeuker JH, de Jong S. Heijink DM, et al. Oncogene. 2011 Apr 28;30(17):2026-36. doi: 10.1038/onc.2010.578. Epub 2011 Jan 10. Oncogene. 2011. PMID: 21217777

8

Involvement of the TGF-beta and beta-catenin pathways in pelvic lymph node metastasis in early-stage cervical cancer.

Noordhuis MG, Fehrmann RS, Wisman GB, Nijhuis ER, van Zanden JJ, Moerland PD, Ver Loren van Themaat E, Volders HH, Kok M, ten Hoor KA, Hollema H, de Vries EG, de Bock GH, van der Zee AG, Schuuring E. Noordhuis MG, et al. Clin Cancer Res. 2011 Mar 15;17(6):1317-30. doi: 10.1158/1078-0432.CCR-10-2320. Epub 2011 Mar 8. Clin Cancer Res. 2011. PMID: 21385933

9

Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patients.

van der Weide K, de Jonge-Peeters S, Huls G, Fehrmann RS, Schuringa JJ, Kuipers F, de Vries EG, Vellenga E. van der Weide K, et al. Exp Hematol. 2012 Mar;40(3):177-186.e6. doi: 10.1016/j.exphem.2011.11.008. Epub 2011 Nov 25. Exp Hematol. 2012. PMID: 22120639 Free article.

10

ATR inhibition preferentially targets homologous recombination-deficient tumor cells.

Krajewska M, Fehrmann RS, Schoonen PM, Labib S, de Vries EG, Franke L, van Vugt MA. Krajewska M, et al. Oncogene. 2015 Jun;34(26):3474-81. doi: 10.1038/onc.2014.276. Epub 2014 Sep 1. Oncogene. 2015. PMID: 25174396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters